NO ASSOCIATION FOUND BETWEEN PATIENTS RECEIVING ISOTRETINOIN FOR ACNE AND THE DEVELOPMENT OF DEPRESSION IN A CANADIAN PROSPECTIVE COHORT
Main Article Content
Keywords
Isotretinoin, depression, acne
Abstract
Background
There has been concern that the use of isotretinoin to treat acne may lead to depression. To date, research has not conclusively determined if this concern is warranted when contemplating the use of isotretinoin.
Objective
This study investigated the impact of isotretinoin use for patients with acne on mood status. The hypothesis was that an association exists between the use of isotretinoin and the development of depression, aside from acne severity.
Methods
We studied the relationship between isotretinoin and depression using a prospective, controlled, cohort design. The study was conducted in a community dermatology clinic. The exposed cohort consisted of consenting patients who were initiating isotretinoin treatment for acne. Patients were either treated with isotretinoin (AcutaneÒ ) therapy (study group) (N=100) or by oral (N=41) or topical acne therapy (control group) (N=59). The Center for Epidemiologic Studies Depression scale and the Zung Depression Status Inventory were used to assess depression both at baseline and after 2 months of prescribed use of isotretinoin or a control medication (topical or oral antibiotics).
Results
There was no correlation between isotretinoin use and the development of depression, based on either the Centre for Epidemiologic Studies Depression scale (Fisher’s exact test, P=0.497) or Zung Depression Status Inventory (ANOVA; F=1.4, P=0.2).
Conclusion
Isotretinoin does not appear to be associated with the development of depression. Thus, denying patients with significant acne an effective medication for fear of developing depression may not be indicated at this point in time.
References
2. Julian CG. Dermatology in general practice. Br J Dermatol 1999;141:518-20.
3. Mallon E, Newton JN, Klassen A, Stewart SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140:672-6.
4. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134:454-8.
5. Barnkin B. Psychosocial effect of common skin diseases. Can Fam Phys 2002;48:712-6.
6. Layton AM. Psychosocial aspects of acne vulgaris. J Cutan Med Surg 1998;2(Suppl 3):S19-23.
7. Bull J. Report before the committee on government house reform, U.S. House of Representatives [Web Page] 5 December 2000; available at http://frwebgate.access.gpo.gov/cgi- bin/getdoc.cgi?dbname=106_house_hearings&d ocid=f:73924.wais.
8. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link? J Am Acad Dermatol 2001;45:S168-75.
9. Wysoski DK, Pitts M, Bietz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-519.
10. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risks of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2002;136:1231- 1236.
11. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Austr Jrnl Dermatol 2002;43:262-268.
12. Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Australian and New Zealand Journal of Psychiatry 2003;37:78- 84.
13. Chia CY, Lane W, Chibnall J, Allen A, Siegfried E. Isotretinoin therapy and moodchanges in adolescents with moderate to severe acne. Arch Dermatol 2005;141:557-560.
14. Bremner JD. Does isotretinoin cause depression and suicide? Psychopharmacology Bulletin. 2003;37(1):64 -78.
15. Magin P, Pond D, Smith W. Isotretinoin, depression and suicide: a review of the evidence. British Journal of General Practice 2005;55(511):134-138.
16. Bremner JD, Fani N, Ashraf A, et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Amer Jrnl Psych 2005;162(5):983-991.
17. Radloff LS. The CES-D scale: a self- report depression scale for research in the general population. Appl Psychol Measurement 1977;1:385-401.
18. Zung WWK. A self- rating depression scale. Arch Gen Psychiatry 1965;12:63- 70.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.